Full Genome Sequencing Explained: Your Body's Complete Instruction Manual
A one-time test. A lifetime of clinical insight.
Full genome sequencing (WGS) analyses the complete DNA sequence of an individual — all 3.2 billion base pairs that constitute the human genome. Unlike targeted panels or SNP arrays, WGS captures the entirety of a patient's genetic blueprint, including rare variants, structural variations, and regions of previously unknown clinical significance.
What WGS Reveals
- Disease risk: variants associated with cardiovascular disease, cancer, metabolic disorders, and neurological conditions.
- Drug response: variants affecting metabolism of medications including statins, antidepressants, anticoagulants, and analgesics.
- Carrier status: recessive conditions relevant to family planning.
- Rare variants: clinically actionable findings that SNP panels would miss.
Once Done, Used Forever
A patient's genome does not change. A test performed today remains clinically relevant for decades. As genomic knowledge advances, previously sequenced data can be reanalysed to yield new insights without additional testing.
At Studio23, we pair full genome sequencing with gut biome analysis to provide a complete biological profile — the permanent genetic context alongside the dynamic physiological reality.
